Minnesota health plans' surprising profits from taxpayer-funded medical assistance programs have drawn scrutiny at the state and federal levels over the past year. Now, state lawmakers are poised to take a responsible step: authorizing an independent evaluation of the state's $3.8 billion-a-year Medicaid managed-care program.
Like many states, Minnesota pays private insurers to administer care and coverage for the poor, elderly or disabled. Bills calling for a limited "third-party audit" appear headed to the House and Senate floors, capping an unprecedented push this session for greater HMO transparency.
Legislators should swiftly pass this legislation. Failing to do so or weakening it would send the wrong message: that lawmakers don't want answers to the serious questions raised about the program.
Concerns about state health plan profits came to a head last spring when UCare, one of the insurers paid to administer Medicaid coverage, unexpectedly gave back $30 million to the state. The state's other big three nonprofits -- Blue Plus, Medica and HealthPartners -- declined similar givebacks. The average Medicaid operating margin for all four big plans was 8.9 percent in 2010.
There are now two separate federal inquiries into the state's Medicaid oversight. One is under seal.
The second is led by U.S. Sen. Chuck Grassley, R-Iowa. Key questions center on whether the state is overpaying the plans and whether it has manipulated payment data to improperly draw down matching federal dollars. (Medicaid is jointly funded by the state and federal governments.)
A report from the Minnesota Department of Health recently underscored the oversight concerns. The report relayed findings from a state advisory group working with an outside firm -- Deloitte Consulting.
The group concluded that the plans' financial reporting made it difficult to determine if their administrative expenses "were reasonable" and whether these expenses and the plans' investment income were being properly allocated. Changes are needed, the report said, to "ensure that publicly funded programs are not subsidizing commercially funded products."